ERBB2 and neoplasm: When comparing the HR+/HER2− ILC patients who converted to node-negative status after NAC versus those who remained ypN+, we did not find differences in age or tumor grade, but there appeared to be fewer premenopausal patients and more H2 tumors among those with nodal pCR (ESM Table S5).